We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go: Stretch investment: Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
Evaclite manufactures dynamic exit signs designed to make buildings safer and save lives. The company argues that its products are 77% more visible than conventional exit signs and reduces congestion at exits by 36%. The company received the 2018 FIREX - Fire Innovation of the Year Award. It also won the Safety and Health Excellence (SHE) Award in 2019 and 2020. Evaclite counts companies like Apple, CBRE, BBC, Melia, and MetroBank amongst its clients. The company has inquiries from over a dozen countries globally with a 12-month sales opportunity pipeline of over £1.5 million. It will use 60% of the investment to build its sales team, 28% to boost its inbound marketing campaign, 7% to develop additional intellectual property, and 5% towards overhead and general costs.

Pitch Rated

81%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £148,736
Findr aims to automate the creation of business partnerships by providing easy access to hyper-targeted opportunities in minutes. The company asserts that its platform allows any business, regardless of its size, to sign up, post its partnership requirements, and explore opportunities for free. The company's portal allows users to request a 1-hour 'Discovery' call with a potential partner when the said user spots a relevant opportunity. Findr argues that it has made 'Discovery' for free for the first few months to build its user base. The company has onboarded 140 business users ranging from early-stage to global brands such as Mastercard, Uber and Visa since November 2020. Findr has featured in Forbes for helping businesses navigate COVID-19. The company will use the investment to develop two new price plans – Unlimited and Enterprise, introduce new platform features, hire a machine learning expert, and undertake digital activity to grow its user base.

Pitch Rated

51%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £396,288
A car-sharing platform for drivers to receive an extra income by allowing the local community to drive their cars instead of leaving it idle and unused. Hiyacar has a acquired an exclusive insurance product with AXA and already has more than 2,000 cars enrolled, with the majority located in London and surrounding urban areas with the intention of expanding further in the future.
days to go: Expired investment: £1,431,885
Creditspring is an innovative subscription-based loan membership company. Its goal is to enable hardworking people to change their lives through access to reliable credit. It allows people to rent a safety net of credit. The company won the Moneynet’s Most Innovative Lender award in January 2019. In July 2019, the company hit 100k membership. Creditspring has been featured in The Times, Forbes and much more favourable press. The company will use the funds to meet the demand for its product.
days to go: Expired investment: £1,571,666
Wealthify is an online investment platform that lets you choose the parameters in which you want to invest such as; how much you want to invest, how long for and the risk level of the investment. 
days to go: Expired investment: £1,117,523
Baanx is a B2B2C mobile banking platform offering cutting-edge services in remittance, spending & blockchain. The company takes pride in its innovative customer acquisition process through partner communities. The BaanxCL already has a CL™ VISA Debit Card, Crypto-Payment Gateway, a Crypto-Exchange, Stablecoins, and other exciting features. The company is also partnering with new brands around the world which are not banking already but have large user communities to connect. The company is aiming to target 100,000 users by Q2 2020 with the assistance of Super Seed Investors. With the proceeds, Baanx will hire additional team members, spend funds on marketing, and launch services in South America and Asia.

Pitch Rated

49%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £658,200
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph